Vaccination status, incidence of adverse events, and awareness of COVID-19 vaccine among outpatients undergoing chemotherapy

Table 4 COVID-19 vaccination profile and adverse events in cancer patients

		1st dose		2nd dose		3rd dose		4th dose
		Number	%	Number	%	Number	%	Number	%
Type of vaccinations	Pfizer	43	74.1	46	79.3	28	59.6	15	71.4
	Moderna	14	24.1	11	19.0	19	40.4	6	28.6
	AstraZeneca	0	0.0	0	0.0	0	0.0	0	0.0
	Others	0	0.0	0	0.0	0	0.0	0	0.0
	I do not know /I do not remember	1	1.7	1	1.7	0	0.0	0	0.0
	Not answer	0	0.0	0	0.0	0	0.0	0	0.0
Impact on cancer treatment schedule	Yes	3	5.2	0	0.0	1	2.1	1	4.8
	No	54	93.1	56	96.6	44	93.6	19	90.5
	Not answer	1	1.7	2	3.4	2	4.3	1	4.8
Presence of adverse events	Shock/Anaphylaxis	0	0.0	0	0.0	0	0.0	0	0.0
	Pain at the injection site	23	39.7	21	36.2	18	38.3	6	28.6
	Swelling at the infection site	10	17.2	10	17.2	9	19.1	4	19.0
	Redness/erythema at the injection site	1	1.7	2	3.4	1	2.1	1	4.8
	Headache	5	8.6	5	8.6	2	4.3	1	4.8
	Diarrhea	0	0.0	0	0.0	0	0.0	0	0.0
	Muscle pain	10	17.2	10	17.2	6	12.8	1	4.8
	Joint pain	6	10.3	6	10.3	6	12.8	1	4.8
	Fatigue	13	22.4	13	22.4	10	21.3	3	14.3
	Cold	5	8.6	5	8.6	6	12.8	0	0.0
	Fever (over 37.5ºC)	21	36.2	17	29.3	13	27.7	3	14.3
	None	27	46.6	28	48.3	24	51.1	14	66.7

ISSN: 2055-0294